IP Library Granted Patent US 9,095,292
Granted Patent B2
US 9,095,292 · App. 13/562,129 · Granted Aug 4, 2015

Analyte concentration detection devices and methods

Inventors: Peter J. Zanzucchi (Princeton Junction, NJ); Sterling E. McBride (Princeton, NJ); Alexei Guennadievich Tsekoun (Princeton, NJ)
Assignee: Intuity Medical, Inc.
A61B5/1459A61B5/14514A61B5/14532A61B5/14546G01N21/03G01N21/359G01N21/7703G01N21/78G01N21/8483G01N33/54373A61B5/1411G01N2021/0325G01N2021/0346Y10T436/144444
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,292
App. No.
13/562,129
Granted
Aug 4, 2015
Kind
B2
Abstract

Arrangements for the detection of the presence and/or concentration of an analyte in a sample of bodily fluid include diffuse transmission, diffuse reflection and edge or waveguide illumination arrangements. A vertical flow assay arrangement and/or technique is also disclosed, and includes a detection component that can be in the form of an array of optical detection elements. A number of assay pad constructions are described which may include at least one or more of the following components: a prefilter component, a reflective component, a membrane component, a reagent component, a mesh component, and a component to prevent lateral spreading.

Claims (12)

1. A device for conducting an assay to determine the concentration of an analyte in a sample of bodily fluid, the device comprising:

a microneedle configured to collect the sample and comprising a lumen therethrough;

an elongate sample collection channel transverse to the lumen of the microneedle, wherein the sample collection channel comprises a proximal end and a distal end, and wherein the proximal end is in communication with the lumen of the microneedle;

an assay pad comprising a reagent that produces a reaction when exposed to the analyte, wherein the assay pad is in communication with the sample collection channel along a length between the proximal and distal ends of the sample collection channel; and

a linear array of detectors configured to scan a line across the assay pad to detect the reaction.

2. The device of claim 1 wherein the linear array of detectors comprises a sensor, the sensor comprising a CMOS sensor, a CCD sensor, or a photodiode.

3. The device of claim 1 , wherein the analyte comprises glucose.

4. The device of claim 1 , wherein the linear array of detectors comprises a linear array of CMOS sensors.

5. The device of claim 1 , further comprising a light source adapted to provide light incident upon the assay pad.

6. The device of claim 1 , further comprising a lens disposed between the linear array of detectors and the assay pad.

7. The device of claim 6 , wherein the lens is a refractive lens.

8. The device of claim 6 , wherein the lens is a diffractive lens.

Assignments (4)
SECURITY INTEREST Recorded May 25, 2021
From: INTUITY MEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 056392/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2014
From: ZANZUCCHI, PETER J.; DESAI, NITIN V.; MCBRIDE, STERLING E.; HO, WEN; VARMA, BOBBY; TSEKOUN, ALEXEI GUENNADIEVICH
To: SARNOFF CORPORATION
Reel/Frame 033161/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2014
From: SARNOFF CORPORATION
To: ROSEDALE MEDICAL, INC.
Reel/Frame 033161/0109 →
CHANGE OF NAME Recorded Jun 23, 2014
From: ROSEDALE MEDICAL, INC.
To: INTUITY MEDICAL, INC.
Reel/Frame 033217/0577 →
Continuity (4)
Continuation 12222724 · Aug 14, 2008
Continuation 11125107 · May 10, 2005
Continuation 10394230 · Mar 24, 2003
Related Publication 20120296179A1 · Nov 22, 2012